Envista (NYSE:NVST) Cut to “Hold” at Zacks Research

Zacks Research cut shares of Envista (NYSE:NVST) from a strong-buy rating to a hold rating in a research report report published on Monday morning,Zacks.com reports.

Several other brokerages have also issued reports on NVST. Evercore reissued an “outperform” rating and issued a $32.00 price target on shares of Envista in a report on Friday, February 6th. Robert W. Baird set a $30.00 price target on shares of Envista in a report on Friday, February 6th. William Blair raised shares of Envista from a “hold” rating to an “outperform” rating in a report on Friday, February 6th. Piper Sandler reissued a “neutral” rating and issued a $25.00 price target (up from $21.00) on shares of Envista in a report on Friday, February 6th. Finally, Weiss Ratings raised shares of Envista from a “sell (d)” rating to a “hold (c-)” rating in a report on Tuesday, February 17th. Seven research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, Envista presently has a consensus rating of “Hold” and an average target price of $27.75.

Envista Price Performance

NVST opened at $26.68 on Monday. The company has a fifty day moving average price of $26.77 and a two-hundred day moving average price of $23.16. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38. Envista has a 52 week low of $14.22 and a 52 week high of $30.42. The firm has a market capitalization of $4.37 billion, a PE ratio of 95.28, a P/E/G ratio of 1.76 and a beta of 0.98.

Envista (NYSE:NVST) last released its earnings results on Thursday, February 5th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same quarter last year, the firm posted $0.24 earnings per share. The firm’s revenue for the quarter was up 15.0% compared to the same quarter last year. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, analysts anticipate that Envista will post 1 earnings per share for the current year.

Insider Buying and Selling at Envista

In other news, SVP Mischa Reis sold 9,675 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the completion of the transaction, the senior vice president directly owned 32,382 shares of the company’s stock, valued at $971,460. This trade represents a 23.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.66% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in NVST. Farther Finance Advisors LLC boosted its holdings in Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock worth $27,000 after purchasing an additional 1,026 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in Envista by 16,711.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after buying an additional 1,504 shares in the last quarter. Allworth Financial LP lifted its position in Envista by 75.4% during the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after buying an additional 776 shares in the last quarter. UMB Bank n.a. lifted its position in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.